Dramatic Shift in the Infantile Hemangioma Treatment Paradigm at a Single Institution
Article first published online: 11 OCT 2013
© 2013 Wiley Periodicals, Inc.
Volume 30, Issue 6, pages 751–752, November/December 2013
How to Cite
Gomulka, J., Siegel, D. H. and Drolet, B. A. (2013), Dramatic Shift in the Infantile Hemangioma Treatment Paradigm at a Single Institution. Pediatric Dermatology, 30: 751–752. doi: 10.1111/pde.12229
- Issue published online: 13 NOV 2013
- Article first published online: 11 OCT 2013
Historically the first line of treatment for infantile hemangiomas (IHs) has been oral corticosteroids, but because of recent discoveries recognizing the effectiveness of oral and topical beta-blockers, IH management is dynamically changing. With these new treatment options, some physicians are altering the way they manage IHs despite having little evidence-based data on the treatment methods. Highlighting treatment changes at a single large tertiary pediatric referral center, we conclude that despite the numerous studies already published on this topic, more reliable prospective studies are needed to determine the safety, efficacy, and best treatment algorithms for the use of topical and oral beta-blockers for the treatment of IHs.